Literature DB >> 25833684

Immunomodulatory adjunctive treatment options for Ebola virus disease patients.

Peter Pickkers1, André van der Ven, Mihai G Netea.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25833684     DOI： 10.1007/s00134-015-3773-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  4 in total

1.  Treatment of Ebola virus disease.

Authors:  Yazdan Yazdanpanah; Jose Ramon Arribas; Denis Malvy
Journal:  Intensive Care Med       Date:  2014-11-11       Impact factor: 17.440

2.  Studying "secret serums"--toward safe, effective Ebola treatments.

Authors:  Jesse L Goodman
Journal:  N Engl J Med       Date:  2014-08-20       Impact factor: 91.245

3.  Ebola hemorrhagic Fever: novel biomarker correlates of clinical outcome.

Authors:  Anita K McElroy; Bobbie R Erickson; Timothy D Flietstra; Pierre E Rollin; Stuart T Nichol; Jonathan S Towner; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2014-02-12       Impact factor: 5.226

4.  Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis.

Authors:  Carl E Allen; Xiaoying Yu; Claudia A Kozinetz; Kenneth L McClain
Journal:  Pediatr Blood Cancer       Date:  2008-06       Impact factor: 3.167
  4 in total
  1 in total

1.  Immunomodulatory adjunctive treatment options for Ebola virus disease patients: another view.

Authors:  David S Fedson
Journal:  Intensive Care Med       Date:  2015-06-03       Impact factor: 17.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.